Mark Waring
Mark Waring
Mark Waring has over 30 years of experience across the pharmaceutical, healthcare, and consulting industries. His areas of expertise include drug development, new molecular entity (NME) discovery, project management, and product development, launch, and marketing.
His early career was spent at the University of Sydney and Royal Prince Alfred Hospital (RPAH) Liver Transplant Unit where he lead a team that developed the first Australian Bio-artificial Liver, which was trialed in humans with liver failure. He also previously headed the Clinical Research and Technical affairs program at an internationally recognized biotechnology company. Most recently, Mark has worked in consulting, advising both large and small clients in clinical research, product approval and launch, professional relationship management, safety surveillance, selection and management of strategic partners and GxP compliant systems.
Mark earned Bachelor of Science and Masters degrees from the University of Sydney and holds Project Management Professional and Pharmaceutical GMP Professional certifications.